Crossmark

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review

Published Online: 2021-01-19

Published Print: 2021-12

Authors

Yang, Chen-Yi

Chen, Ying-Ren

Ou, Huang-Tz http://orcid.org/0000-0002-5475-7848
Kuo, Shihchen
Funding

Funding for this research was provided by:

Ministry of Science and Technology, Taiwan (MOST 109-2320-B-006-047)

National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092926)
License Information

Text and Data Mining valid from 2021-01-19

Version of Record valid from 2021-01-19
More Information

Article History

Received: 27 October 2020

Accepted: 30 December 2020

First Online: 19 January 2021

Ethics approval and consent to participate

: This study was approved by the Institutional Review Board of National Cheng Kung University (A-EX-106-013).

: Not applicable.

: No competing interests to be declared.

Document is current